The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmaceutical Co-Packing-Global Market Insights and Sales Trends 2024
Synopsis
The global Pharmaceutical Co-Packing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Co-Packing in various end use industries. The expanding demands from the OTC Pharmaceutical Companies, RX Pharmaceutical Companies and Others,, are propelling Pharmaceutical Co-Packing market. Plastic Bottles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blister Packs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Co-Packing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Co-Packing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Co-Packing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Co-Packing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Co-Packing covered in this report include Cardinal Health, CCL Industries, PCI Pharma Services, Sharp Packaging Services, Berlin Packaging, TricorBraun, Pharma Packaging Solutions, Unicep Packaging and Baxter BioPharma Solutions, etc.
The global Pharmaceutical Co-Packing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cardinal Health
CCL Industries
PCI Pharma Services
Sharp Packaging Services
Berlin Packaging
TricorBraun
Pharma Packaging Solutions
Unicep Packaging
Baxter BioPharma Solutions
Jones Packaging Inc.
Ropack Pharma Solutions
Reed-Lane
Precision Medical Products, Inc.
Global Pharmaceutical Co-Packing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Co-Packing market, Segment by Type:
Plastic Bottles
Blister Packs
Glass Containers
Others
Global Pharmaceutical Co-Packing market, by Application
OTC Pharmaceutical Companies
RX Pharmaceutical Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Co-Packing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Pharmaceutical Co-Packing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Co-Packing in various end use industries. The expanding demands from the OTC Pharmaceutical Companies, RX Pharmaceutical Companies and Others,, are propelling Pharmaceutical Co-Packing market. Plastic Bottles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blister Packs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Co-Packing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Co-Packing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Co-Packing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Co-Packing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Co-Packing covered in this report include Cardinal Health, CCL Industries, PCI Pharma Services, Sharp Packaging Services, Berlin Packaging, TricorBraun, Pharma Packaging Solutions, Unicep Packaging and Baxter BioPharma Solutions, etc.
The global Pharmaceutical Co-Packing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cardinal Health
CCL Industries
PCI Pharma Services
Sharp Packaging Services
Berlin Packaging
TricorBraun
Pharma Packaging Solutions
Unicep Packaging
Baxter BioPharma Solutions
Jones Packaging Inc.
Ropack Pharma Solutions
Reed-Lane
Precision Medical Products, Inc.
Global Pharmaceutical Co-Packing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Co-Packing market, Segment by Type:
Plastic Bottles
Blister Packs
Glass Containers
Others
Global Pharmaceutical Co-Packing market, by Application
OTC Pharmaceutical Companies
RX Pharmaceutical Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Co-Packing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmaceutical Co-Packing
1.1 Pharmaceutical Co-Packing Market Overview
1.1.1 Pharmaceutical Co-Packing Product Scope
1.1.2 Pharmaceutical Co-Packing Market Status and Outlook
1.2 Global Pharmaceutical Co-Packing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Co-Packing Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Co-Packing Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Co-Packing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Co-Packing Market Size (2018-2029)
1.6.1 North America Pharmaceutical Co-Packing Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Co-Packing Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Co-Packing Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Co-Packing Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Co-Packing Market Size (2018-2029)
2 Pharmaceutical Co-Packing Market by Type
2.1 Introduction
2.1.1 Plastic Bottles
2.1.2 Blister Packs
2.1.3 Glass Containers
2.1.4 Others
2.2 Global Pharmaceutical Co-Packing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Co-Packing Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Co-Packing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Co-Packing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Co-Packing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Co-Packing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Co-Packing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Co-Packing Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Co-Packing Market Overview by Application
3.1 Introduction
3.1.1 OTC Pharmaceutical Companies
3.1.2 RX Pharmaceutical Companies
3.1.3 Others
3.2 Global Pharmaceutical Co-Packing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Co-Packing Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Co-Packing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Co-Packing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Co-Packing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Co-Packing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Co-Packing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Co-Packing Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Co-Packing Competition Analysis by Players
4.1 Global Pharmaceutical Co-Packing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Co-Packing as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Co-Packing Market
4.4 Global Top Players Pharmaceutical Co-Packing Headquarters and Area Served
4.5 Key Players Pharmaceutical Co-Packing Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Co-Packing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cardinal Health
5.1.1 Cardinal Health Profile
5.1.2 Cardinal Health Main Business
5.1.3 Cardinal Health Pharmaceutical Co-Packing Products, Services and Solutions
5.1.4 Cardinal Health Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.1.5 Cardinal Health Recent Developments
5.2 CCL Industries
5.2.1 CCL Industries Profile
5.2.2 CCL Industries Main Business
5.2.3 CCL Industries Pharmaceutical Co-Packing Products, Services and Solutions
5.2.4 CCL Industries Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.2.5 CCL Industries Recent Developments
5.3 PCI Pharma Services
5.3.1 PCI Pharma Services Profile
5.3.2 PCI Pharma Services Main Business
5.3.3 PCI Pharma Services Pharmaceutical Co-Packing Products, Services and Solutions
5.3.4 PCI Pharma Services Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.3.5 Sharp Packaging Services Recent Developments
5.4 Sharp Packaging Services
5.4.1 Sharp Packaging Services Profile
5.4.2 Sharp Packaging Services Main Business
5.4.3 Sharp Packaging Services Pharmaceutical Co-Packing Products, Services and Solutions
5.4.4 Sharp Packaging Services Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.4.5 Sharp Packaging Services Recent Developments
5.5 Berlin Packaging
5.5.1 Berlin Packaging Profile
5.5.2 Berlin Packaging Main Business
5.5.3 Berlin Packaging Pharmaceutical Co-Packing Products, Services and Solutions
5.5.4 Berlin Packaging Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.5.5 Berlin Packaging Recent Developments
5.6 TricorBraun
5.6.1 TricorBraun Profile
5.6.2 TricorBraun Main Business
5.6.3 TricorBraun Pharmaceutical Co-Packing Products, Services and Solutions
5.6.4 TricorBraun Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.6.5 TricorBraun Recent Developments
5.7 Pharma Packaging Solutions
5.7.1 Pharma Packaging Solutions Profile
5.7.2 Pharma Packaging Solutions Main Business
5.7.3 Pharma Packaging Solutions Pharmaceutical Co-Packing Products, Services and Solutions
5.7.4 Pharma Packaging Solutions Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.7.5 Pharma Packaging Solutions Recent Developments
5.8 Unicep Packaging
5.8.1 Unicep Packaging Profile
5.8.2 Unicep Packaging Main Business
5.8.3 Unicep Packaging Pharmaceutical Co-Packing Products, Services and Solutions
5.8.4 Unicep Packaging Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.8.5 Unicep Packaging Recent Developments
5.9 Baxter BioPharma Solutions
5.9.1 Baxter BioPharma Solutions Profile
5.9.2 Baxter BioPharma Solutions Main Business
5.9.3 Baxter BioPharma Solutions Pharmaceutical Co-Packing Products, Services and Solutions
5.9.4 Baxter BioPharma Solutions Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.9.5 Baxter BioPharma Solutions Recent Developments
5.10 Jones Packaging Inc.
5.10.1 Jones Packaging Inc. Profile
5.10.2 Jones Packaging Inc. Main Business
5.10.3 Jones Packaging Inc. Pharmaceutical Co-Packing Products, Services and Solutions
5.10.4 Jones Packaging Inc. Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.10.5 Jones Packaging Inc. Recent Developments
5.11 Ropack Pharma Solutions
5.11.1 Ropack Pharma Solutions Profile
5.11.2 Ropack Pharma Solutions Main Business
5.11.3 Ropack Pharma Solutions Pharmaceutical Co-Packing Products, Services and Solutions
5.11.4 Ropack Pharma Solutions Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.11.5 Ropack Pharma Solutions Recent Developments
5.12 Reed-Lane
5.12.1 Reed-Lane Profile
5.12.2 Reed-Lane Main Business
5.12.3 Reed-Lane Pharmaceutical Co-Packing Products, Services and Solutions
5.12.4 Reed-Lane Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.12.5 Reed-Lane Recent Developments
5.13 Precision Medical Products, Inc.
5.13.1 Precision Medical Products, Inc. Profile
5.13.2 Precision Medical Products, Inc. Main Business
5.13.3 Precision Medical Products, Inc. Pharmaceutical Co-Packing Products, Services and Solutions
5.13.4 Precision Medical Products, Inc. Pharmaceutical Co-Packing Revenue (US$ Million) & (2018-2023)
5.13.5 Precision Medical Products, Inc. Recent Developments
6 North America
6.1 North America Pharmaceutical Co-Packing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Co-Packing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Co-Packing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Co-Packing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Co-Packing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Co-Packing Market Dynamics
11.1 Pharmaceutical Co-Packing Industry Trends
11.2 Pharmaceutical Co-Packing Market Drivers
11.3 Pharmaceutical Co-Packing Market Challenges
11.4 Pharmaceutical Co-Packing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
